Yi-Ching Yang

Prof. Dr. Yi-Ching Yang

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Psychiatry Research
Verified
Journal Article
Closed access
HTHsing Fang Tsai
Hsing Fang Tsai
SCShu Hui Cheng
Shu Hui Cheng
TYTzung Lieh Yeh
Tzung Lieh Yeh
CSChi-Chen Shih
Chi-Chen Shih
KCKao Ching Chen
Kao Ching Chen
YYYen Kuang Yang
Yen Kuang Yang

1 May 2012 in Psychiatry Research
Verified
Journal Article
Closed access
SCShu Hui Cheng
Shu Hui Cheng
CSChi-Chen Shih
Chi-Chen Shih
ILI. Hui Lee
I. Hui Lee
YHYi-Wen Hou
Yi-Wen Hou
KCKao Chin Chen
Kao Chin Chen
YYYi-Ching Yang
Yi-Ching Yang

26 July 2004 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
YYYi-Ching Yang
Yi-Ching Yang
FLFeng-Hwa Lu
Feng-Hwa Lu
JWJin-Shang Wu
Jin-Shang Wu
CWChih-Hsing Wu
Chih-Hsing Wu
CCChih-Jen Chang
Chih-Jen Chang
Tea, having been brewed from the leaves of the Camellia sinensis for almost 4000 years, is the most popularly consumed beverage worldwide, second only to water, with a per capita worldwide consumption of approximately 0.12 L/y.1 Owing to the high consumption of tea, even small effects in persons could have a large effect on public health. Tea contains more than 4000 chemical compounds that may affect the human body in many aspects.2,3 There has been a growing interest in recent years in exploring the preventive effect of tea, especially polyphenolic flavonoids in tea, against cardiovascular diseases (CVDs)4-8 and the development and progression of atherosclerosis.9,10 The delicate mechanisms responsible for the benefits of tea with regard to cardiovascular risk are, however, unclear.

14 February 2003 in International Journal of Obesity
Verified
Journal Article
Closed access
CCC-J Chang
C-J Chang
CWC-H Wu
C-H Wu
CCC-S Chang
C-S Chang
WYW-J Yao
W-J Yao
YYYi-Ching Yang
Yi-Ching Yang
FLF-H Lu
F-H Lu

3 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HOHorng-Yih Ou
Horng-Yih Ou
CWChi-Chuan Wang
Chi-Chuan Wang
YYYi-Ching Yang
Yi-Ching Yang
YCYUNG-MING CHEN
YUNG-MING CHEN
CCChih-Jen Chang
Chih-Jen Chang
Background Fatty infiltration of the pancreas has been shown to interfere with insulin secretion. Both insulin sensitivity and secretion are important in the pathogenesis of diabetes and prediabetes. However, the relationship between diabetes, prediabetes, and fatty pancreas remains unknown. We aim to investigate the relationships that fatty pancreas and nonalcoholic fatty liver disease (NAFLD) have with prediabetes and diabetes in a Chinese population. Patients and Methods This was a cross-sectional study. A total of 7,464 subjects were recruited. NAFLD and fatty pancreas were assessed by sonography. Clinico-metabolic parameters were compared among subjects with normoglycemia, prediabetes, and diabetes. Multinomial logistic regression was used to evaluate the relationship between fatty pancreas and NAFLD and diabetes or prediabetes with adjustment for cardiometabolic risk factors. Results With an increase in glycemia, a significantly greater proportion of subjects had NAFLD and fatty pancreas (test for trend p <0.05). Similar trends were also found for hypertension, general and central obesity, low-HDL cholesterol, and hypertriglyceridemia. In the logistic regression analysis, age, hypertension, male gender, hypertriglyceridemia, and central obesity were significantly associated with prediabetes and diabetes. Furthermore, the ORs of prediabetes and diabetes for NAFLD were 1.798 (95% CI 1.544–2.094) and 2.578 (95% CI 2.024–3.284), respectively. In addition, fatty pancreas was independently related to diabetes (OR, 1.379; 95% CI, 1.047–1.816) and prediabetes (OR, 1.222; 95% CI, 1.002–1.491) in male subjects. Conclusions Both NAFLD and fatty pancreas were associated with diabetes independent of age, gender, adiposity, and other cardiometabolic risk factors. Fatty pancreas was also related to prediabetes in males.

1 October 2009 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
TLTa-Chung Lee
Ta-Chung Lee
How-Ran GuoHow-Ran Guo
How-Ran Guo
HSHuey-Jen Su
Huey-Jen Su
YYYi-Ching Yang
Yi-Ching Yang
HCHsiao-Ling Chang
Hsiao-Ling Chang
KCKow-Tong Chen
Kow-Tong Chen
The purpose of this review was to explore the epidemiology, pathogenesis, virology, and management of enterovirus 71 (EV71) infection. Published literature was surveyed by Medline using the keyword “EV71.” The reported incidence of cases of hand-foot-mouth disease/herpangina varied from year to year; seasonal variations in incidence were observed, with a peak in incidence during the summer season. Most cases of hand-foot-mouth disease/herpangina hospitalized for complications occurred in children less than 5 years old. The brainstem was the most likely major target of EV71 infection. Different enteroviruses cocirculate in the community annually. The emergence of the EV71 epidemic in the Asia Pacific region has been associated with the circulation of 5 genetic lineages (genotypes B3, B4, C1, C2, C4) that appear to be undergoing rapid evolutionary changes. The relationship between the gene structure of the EV71 virus and the factors that ensure its survival, ease of transmission, and evasion of immunity is still unclear. EV71 central nervous system involvement causes serious clinical illness, death, and long-term neurologic and psychiatric disorders in young children. EV71 infection has emerged as an important public health problem. Vaccine development is recommended for the prevention of EV71 infection in the future.